Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American …
LH de Oliveira, LAB Camacho, ESF Coutinho… - PLoS one, 2016 - journals.plos.org
Background Several Latin American and Caribbean (LAC) countries have introduced
pneumococcal conjugate vaccine (PCV-10 or PCV-13) in their routine national immunization …
pneumococcal conjugate vaccine (PCV-10 or PCV-13) in their routine national immunization …
Impact of pneumococcal conjugate vaccines for children in high-and non–high-income countries
R Cohen, JF Cohen, M Chalumeau… - Expert review of …, 2017 - Taylor & Francis
Introduction: The high level of effectiveness of pneumococcal conjugate vaccines (PCVs)
was demonstrated initially in high-income countries (HICs). However, because the burden of …
was demonstrated initially in high-income countries (HICs). However, because the burden of …
Global case fatality of bacterial meningitis during an 80-year period: a systematic review and meta-analysis
CN van Ettekoven, FD Liechti, MC Brouwer… - JAMA Network …, 2024 - jamanetwork.com
Importance The impact of vaccination, antibiotics, and anti-inflammatory treatment on
pathogen distribution and outcome of bacterial meningitis over the past century is uncertain …
pathogen distribution and outcome of bacterial meningitis over the past century is uncertain …
Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: a time-series analysis
AL Andrade, R Minamisava, G Policena… - Human vaccines & …, 2016 - Taylor & Francis
Routine infant immunization with 10-valent pneumococcal conjugate vaccine (PCV-10)
began in Brazil in 2010. The impact of the PCV-10 on rates of invasive pneumococcal …
began in Brazil in 2010. The impact of the PCV-10 on rates of invasive pneumococcal …
Incidence and aetiology of bacterial meningitis among children aged 1–59 months in South Asia: systematic review and meta-analysis
Background Bacterial meningitis is a significant cause of morbidity and mortality worldwide
among children aged 1–59 months. We aimed to describe its burden in South Asia, focusing …
among children aged 1–59 months. We aimed to describe its burden in South Asia, focusing …
Emergence of serotype 19A Streptococcus pneumoniae after PCV10 associated with a ST320 in adult population, in Porto Alegre, Brazil
MP Mott, J Caierão, GR Cunha… - Epidemiology & …, 2019 - cambridge.org
Use of pneumococcal conjugate vaccines has caused emergence of non-vaccine serotypes.
No Brazilian data specifically about serotype 19A are available. We aimed to evaluate the …
No Brazilian data specifically about serotype 19A are available. We aimed to evaluate the …
[HTML][HTML] Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national immunization program
M Moreira, O Cintra, J Harriague, WP Hausdorff, B Hoet - Vaccine, 2016 - Elsevier
Brazil introduced the 10-valent pneumococcal non-typeable Haemophilus influenzae
protein D conjugate vaccine (PHiD-CV, Synflorix™, GSK Vaccines) in the routine childhood …
protein D conjugate vaccine (PHiD-CV, Synflorix™, GSK Vaccines) in the routine childhood …
[PDF][PDF] Camacho LAB, Coutinho ESF, Martinez-Silveira MS, Carvalho AF, Ruiz-Matus C, et al.(2016) Impact and Effectiveness of 10 and 13-Valent Pneumococcal …
LH De Oliveira - PLoS One, 2016 - academia.edu
Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on
Hospitalization and Mortality in Children Aged L Page 1 RESEARCH ARTICLE Impact and …
Hospitalization and Mortality in Children Aged L Page 1 RESEARCH ARTICLE Impact and …
A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016)
M Moreira, O Castro, M Palmieri, S Efklidou… - Human Vaccines & …, 2017 - Taylor & Francis
Higher-valent pneumococcal conjugate vaccines (PCVs) were licensed from 2009 in
Europe; similar worldwide clinical effectiveness was observed for PCVs in routine use …
Europe; similar worldwide clinical effectiveness was observed for PCVs in routine use …
[HTML][HTML] Changing trends in serotypes of S. pneumoniae isolates causing invasive and non-invasive diseases in unvaccinated population in Mexico (2000-2014)
MN Carnalla-Barajas, A Soto-Noguerón… - International Journal of …, 2017 - Elsevier
Objective Introduction of pneumococcal conjugate vaccines (PCV) targeted against a limited
number of serotypes substantially decreased invasive (IPD) and non-invasive …
number of serotypes substantially decreased invasive (IPD) and non-invasive …